Metoprolol succinate

Product NDC: 68151-1840
11-digit product format: 681511840
Labeler code: 68151
Product ID: 68151-1840_81a67005-eb73-4722-8cfb-96b92d907fbf
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Metoprolol succinate
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Labeler: Carilion Materials Management
Application: ANDA090617
Marketing category: ANDA
Marketing start: 2014-01-01
Marketing end: 0000-00-00
Substance: METOPROLOL SUCCINATE
Active strength: 50 mg/1
Pharmacologic classes: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	68151-1840		I	Inactivated by FDA		2026-10-05
excluded package	package	68151-1840	68151-1840-0	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68151-1840-0	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68151-1840-0	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68151-1840-0	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68151-1840-0	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68151-1840-0	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68151-1840-0	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68151-1840-0	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68151-1840-0	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68151-1840-0	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68151-1840-0	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	68151-1840-0	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	68151-1840-0	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	68151-1840-0	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	68151-1840-0	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	68151-1840-0	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	68151-1840-0	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	68151-1840-0	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	68151-1840-0	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	68151-1840-0	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	68151-1840-0	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	68151-1840-0	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	68151-1840-0	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A090617-001	METOPROLOL SUCCINATE	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB		2012-08-01
A090617-002	METOPROLOL SUCCINATE	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB		2012-08-01

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A090617-001	AB
A090617-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A090617-001	METOPROLOL SUCCINATE	EQ 25MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090617-002	METOPROLOL SUCCINATE	EQ 50MG TARTRATE	TABLET, EXTENDED RELEASE / ORAL	AB	2012-08-01	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A090617-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A090617-002	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A090617-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A090617-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A090617-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090617-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090617-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090617-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A090617-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090617-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090617-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090617-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090617-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090617-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090617-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090617-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090617-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090617-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090617-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090617-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090617-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090617-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A090617-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A090617-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090617-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090617-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090617-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090617-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090617-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090617-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A090617-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A090617-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090617-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090617-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A090617-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A090617-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A090617-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A090617-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A090617-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090617-002	AB	1	`74a2ff9319b5…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fac0d979-ed64-4395-be9a-fc0b6f8c0a4f	Product name	1	20260122
e1a63b6e-1877-c2c1-01a3-03ea2817aa6f	Product name	3	20251027
07ea0487-5434-6896-2497-013a7ee4afbd	Product name	9	20250311
95ced987-af5e-4bea-8119-4e7d4558d21b	Product name	2	20200617
47fc2fe9-7afb-4be9-989d-787aaa6ad0ea	Product name	1	20200505
9ab5a42a-e77d-486b-bb1f-b343fe664ada	Product name	1	20180430
310125de-e7c0-730d-d178-98b990a0334a	Product name	2	20150324

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68151-1840-0	2020-01-31	C162847	48780-1	9d75b9d0-72e8-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 1992

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68151-1840-0	Metoprolol succinate	1 in 1 PACKAGE	TABLET, EXTENDED RELEASE	1		3

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
METOPROLOL SUCCINATE	ACTIVE INGREDIENT	TH25PD4CCB	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
METOPROLOL	ACTIVE MOIETY	GEB06NHM23	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
ACETYLTRIBUTYL CITRATE	INACTIVE INGREDIENT	0ZBX0N59RZ	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
ETHYLCELLULOSE (10 MPA.S)	INACTIVE INGREDIENT	3DYK7UYZ62	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
HYDROGENATED COTTONSEED OIL	INACTIVE INGREDIENT	Z82Y2C65EA	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
METHYLENE CHLORIDE	INACTIVE INGREDIENT	588X2YUY0A	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
POLYETHYLENE GLYCOL 6000	INACTIVE INGREDIENT	30IQX730WE	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
SODIUM STEARYL FUMARATE	INACTIVE INGREDIENT	7CV7WJK4UI	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68151-1840	METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	3	Legacy NDC, 1 package rows	20140708_8cdaeafa-2255-4122-a016-853b3ed6a19b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 24 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Metoprolol succinate	METOPROLOL SUCCINATE	Redpharm Drug	5a65a60c-4c0d-e89b-e063-6394a90ac689	2026-09-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Redpharm Drug	58be9439-7943-3e41-e063-6394a90adddc	2026-08-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol Succinate	METOPROLOL SUCCINATE	American Health Packaging	74e3b4dc-eb30-4d7c-a558-cf58f6470496	2026-06-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Aphena Pharma Solutions - Tennessee, LLC	522c40f2-80f1-e2fc-e063-6294a90ad091	2026-05-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Aphena Pharma Solutions - Tennessee, LLC	51b630c7-6c03-7876-e063-6294a90acb30	2026-05-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol Succinate	METOPROLOL SUCCINATE	Cardinal Health 107, LLC	028049cd-d233-49f9-87fa-ec91e433a49f	2026-04-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Major Pharmaceuticals	14ab9921-4651-4abc-92dc-aab1719b6bb0	2026-03-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Dr. Reddy's Laboratories Inc	24c87741-ee0a-738e-2c5a-5ce80ca2f48b	2026-01-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	PD-Rx Pharmaceuticals, Inc.	4eea76dd-af6d-419a-90e4-ba9eff3b2c73	2025-10-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	PD-Rx Pharmaceuticals, Inc.	947f7982-2aea-40fb-a93b-c0a28f89da85	2025-10-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	A-S Medication Solutions	114346a1-ce49-49d2-9674-2fa6a49749c3	2025-09-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	A-S Medication Solutions	46c288aa-a55c-4207-9a6e-ceef3c2f60ff	2025-09-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	AvPAK	71b27b55-44aa-113d-e053-2995a90a1cf7	2025-08-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Cardinal Health 107, LLC	e2f8dd23-600f-460e-aced-4e13504628f1	2025-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Cardinal Health 107, LLC	1ab032d6-db68-4108-85d1-56e828d0dc01	2025-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Cardinal Health 107, LLC	f6689572-d53d-49eb-a932-85056612a355	2025-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Quallent Pharmaceuticals Health LLC	250c2428-c8b0-5156-697a-60cb8a45713c	2025-07-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	Northstar Rx LLC	ad097646-cc77-8d67-5974-cc00060409f2	2025-07-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	NuCare Pharmaceutcals, Inc.	32341a31-a2db-cf13-e063-6394a90aad89	2025-04-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617
Metoprolol succinate	METOPROLOL SUCCINATE	NCS HealthCare of KY, LLC dba Vangard Labs	c4fb991c-025c-4a1d-9766-4b62ad70b5fe	2025-02-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090617 application number: ANDA090617

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
TH25PD4CCB	METOPROLOL SUCCINATE	98418-47-4	METOPROLOL SUCCINATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
866436	metoprolol succinate 50 MG 24HR Extended Release Oral Tablet	PSN	8cdaeafa-2255-4122-a016-853b3ed6a19b	3
866436	24 HR metoprolol succinate 50 MG Extended Release Oral Tablet	SCD	8cdaeafa-2255-4122-a016-853b3ed6a19b	3
866436	24 HR metoprolol succinate 50 MG (as metoprolol succinate 47.5 MG equivalent to 50 MG metoprolol tartrate) Extended Release Oral Tablet	SY	8cdaeafa-2255-4122-a016-853b3ed6a19b	3
866436	metoprolol succinate 50 MG 24 HR Extended Release Oral Tablet	SY	8cdaeafa-2255-4122-a016-853b3ed6a19b	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
68151-1840-0	68151184000	1 in 1 PACKAGE	Historical